Mammographic Density and Breast Cancer Risk Assessment

Mammographic density refers to the proportion of fibroglandular tissue relative to fatty tissue visible on a mammogram. Higher density both masks lesions on imaging and independently elevates breast cancer risk, making it a critical factor in screening and prevention strategies. Traditionally assessed by visual or semi-automated area-based methods, advances in digital mammography and automated volumetric techniques have improved reproducibility and objectivity. Integration of density measures into established risk models—such as the Tyrer-Cuzick and Gail tools—enhances individualized risk estimation, guiding decisions on screening intervals, supplemental imaging and preventive interventions. Emerging evidence underscores the value of longitudinal assessment of density change as an early marker of risk modulation, while artificial intelligence (AI)-driven feature extraction enables multifactorial models that combine density with microcalcification and mass patterns. Globally, variations in legislation governing density notification and supplemental screening underscore the need for harmonised guidelines. As breast cancer incidence continues to rise, refined density assessment underpins risk-adapted screening programmes, optimising resource allocation and potentially reducing late-stage diagnoses through targeted surveillance.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Mammographic Density and Breast Cancer Risk Assessment publication trend

The graph below shows the total number of articles in mammographic density and breast cancer risk assessment across all publications each year (not limited to Nature Index journals).

Technical terms

Mammographic density: The proportion of radiopaque fibroglandular tissue relative to radiolucent fatty tissue on a mammogram, expressed as a percentage or category.

Volumetric density: An automated measure estimating absolute and percentage fibroglandular tissue volume in three dimensions from digital mammograms.

Risk stratification: The process of classifying individuals into risk groups based on clinical, imaging or molecular factors to guide screening and prevention strategies.

Interval cancer: A breast cancer diagnosed after a negative screening examination and before the next scheduled screen, often indicating reduced screening sensitivity.

Area under the receiver operating characteristic curve (AUC): A statistical metric quantifying a model’s ability to discriminate between individuals who will and will not develop disease, with 1.0 indicating perfect discrimination.

References

1. An optimization framework to guide the choice of thresholds for risk-based cancer screening. npj Digital Medicine (2023).
2. Longitudinal Analysis of Change in Mammographic Density in Each Breast and Its Association With Breast Cancer Risk. JAMA Oncology (2023).
3. European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening—a nested case-control study. The Lancet Regional Health - Europe (2023).
4. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Research (2015).